UK Ibrance Patient Program (IPP) Study

Condition:   HR+/HER2- Locally Advanced, Metastatic Breast Cancer Intervention:   Drug: Palbociclib Sponsor:   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials